News

With proper and timely diagnosis of this childhood cancer, along with access to care and a robust treatment plan, pediatric ...
For patients with multiple myeloma, the use of novel agents in first-line triplet and quadruplet induction regimens -- with or without high-dose therapy and autologous stem cell transplant (ASCT) -- ...
Mr Reynolds said losing Willow was "devastating" and he is holding an event at Lambourn Sports Club in Berkshire to raise ...
MRI showed a renal mass with thick septa and progressive enhancement after gadolinium injection. The lesion was interpreted as a complex renal cystic lesion, classified as Bosniak IV (Figures 2 – 5).
A brain abscess is a rare but life-threatening infection. Learn how advances in imaging, surgery, and diagnostics are ...
Multiple myeloma causes lytic or osteolytic lesions, which are areas of damage caused by cancerous plasma cells blocking normal bone growth. While painful, they can be managed. Multiple myeloma is ...
The IMPACT-RCC study 7 evaluated visualization of clear cell RCC lesions in 42 patients with metastatic disease (n = 449 lesions). Patients in this study had a lesion size cutoff of 1 cm (lymph nodes ...
In one patient, total body scans were performed at 15 minutes, 1 hour, 2 hours, and 4 hours post-injection. The effective dose was 0.022 mSv/MBq, with the stomach wall receiving the highest organ dose ...
The skin is the largest organ of the body, and works as a protective shield against the outside world. It protects us, and ...
At the John Hopkins Medical Institution 33.6% of 217 renal masses that were removed by laparoscopic partial nephrectomy between January 1999 and March 2004 were found to be benign after surgery. [44] ...
A new cancer treatment that delivers radiation directly to tumors by targeting two key markers simultaneously has been shown ...
Belzutifan is a hypoxia-inducible factor-2α inhibitor that is US FDA approved for the treatment of VHL disease-associated renal cell carcinoma (RCC), CNS hemangioblastomas, or pancreatic ...